Hoppa till huvudinnehållet

CSL Behring in Iceland

Driven by Our Promise

It began with a promise. More than 100 years ago, CSL was formed to save lives using the latest technologies. In the century since, CSL Behring has grown into a global biotechnology leader, driven by that same promise to save and improve lives. We offer the broadest range of quality plasma-derived and recombinant therapies in our industry. Our ability to innovate and deliver life-saving medicines for patients with unmet medical needs around the world has earned us a reputation for always putting patients first. We are CSL Behring and we are driven by our promise.

Read our Corporate Brochure or view our Fact Sheet.

Our head office for the Nordic Region is in Sweden and has representatives in Denmark, Finland, Norway, and Sweden. Our Danish representative is also contact person for Iceland and can be reached by phone or email as detailed below:

Mette Toft Jacobsen
Country Sales Manager 
Dir tlf.: +45 24 48 56 85 
Email: Click here


Disclosure reports for Iceland can be found on the Icelandic Association of the Pharmaceutical Industry's homepage Frumtök

Our Products

CSL Behring is a specialty biotherapeutics company. Biotherapies differ from conventional chemical-based pharmaceuticals in that they derive from human blood plasma or are manufactured using recombinant technologies. CSL Behring is proud to serve communities of people who have von Willebrand disease (VWD), hemophilia, primary immunodeficiency (PID), hereditary angioedema (HAE), Alpha-1 antitrypsin deficiency, fibrinogen deficiency and other rare diseases. We also manufacture biotherapies to prevent hemolytic disease of the newborn, and biotherapies preventing or stopping bleeding in emergencies or planned surgery.

Product List for Iceland

We currently market the following products in Iceland.
All of our products are by prescription only.

Afstyla® | lonoctocog alfa
Samantekt á Eiginleikum Lyfs

Alburex® 50 g/l
Samantekt á Eiginleikum Lyfs
Alburex® 200 g/l
Samantekt á Eiginleikum Lyfss
Berinert® 500 IU/1500IU, Acute
Samantekt á Eiginleikum Lyfs

Berinert® 2000/3000 IU, Prevention
Samantekt á Eiginleikum Lyfs

Samantekt á Eiginleikum Lyfs
Samantekt á Eiginleikum Lyfs
Privigen® | Immunoglobulinum humanum INN
Samantekt á Eiginleikum Lyfs
Rhophylac® | Immunoglobulin-Anti D
Samantekt á Eiginleikum Lyfs
Riastap® | Fibrinogen
Samantekt á Eiginleikum Lyfs

Patient Associations

The Icelandic Hemophilia Society  Blæðarafélag Íslands
Global organisation for hemophilia  World Federation of Hemophilia

Immune Deficiency:
International Patient Organisation for Patients with Primary Immunodeficiencies  IPOPI
Icelandic Immune Deficiency Foundation  Lind

Hereditary Angioedema:
International patient organisation for C1 inhibitor deficiencies  HAEi 


Hemophilia Treatment Centre:

The Reykjavik Hemophilia Center is located at Landspitali University Hospital in Reykjavik.

Contact: Office at +354-543-5010 or hospital operator at (+354)-543-1000. Hemophilia center e-mail address: blaedaramidstod@landspitali.is.